James E. Audia
Directeur/Membre du Conseil chez Ribon Therapeutics, Inc.
Postes actifs de James E. Audia
Sociétés | Poste | Début | Fin |
---|---|---|---|
Ribon Therapeutics, Inc.
Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Directeur/Membre du Conseil | 01/04/2018 | - |
Alzheimer’s Association
Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services The Alzheimer's Association is based in Chicago, IL and has subsidiaries in the United States. The Alzheimer's Association provides information and resources for Alzheimer's and other dementias. Alzheimer’s Association was founded in 1980. Joanne Pike has been the CEO of the company since 2016. | Corporate Officer/Principal | 01/01/2020 | - |
Historique de carrière de James E. Audia
Anciens postes connus de James E. Audia
Sociétés | Poste | Début | Fin |
---|---|---|---|
KARA THER | Corporate Officer/Principal | 01/11/2019 | 18/03/2024 |
CONSTELLATION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/07/2017 | 15/07/2021 |
Directeur Technique/Scientifique/R&D | 05/01/2011 | 01/07/2017 | |
Independent Dir/Board Member | 01/07/2017 | 15/07/2021 | |
Chicago Biomedical Consortium | Directeur/Membre du Conseil | 01/08/2017 | 01/10/2019 |
Formation de James E. Audia
University of South Carolina | Doctorate Degree |
Yale University | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Opérationnelle
Director/Board Member | 3 |
Doctorate Degree | 2 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 5 |
---|---|
Constellation Pharmaceuticals, Inc.
Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Chicago Biomedical Consortium | |
Ribon Therapeutics, Inc.
Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Health Technology |
Alzheimer’s Association
Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services The Alzheimer's Association is based in Chicago, IL and has subsidiaries in the United States. The Alzheimer's Association provides information and resources for Alzheimer's and other dementias. Alzheimer’s Association was founded in 1980. Joanne Pike has been the CEO of the company since 2016. | Commercial Services |
Karuna Therapeutics, Inc.
Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- James E. Audia
- Expérience